Pharmaceutical compositions comprising 2-[6-(3-Amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile andpharmaceutically acceptable salts thereof are provided as well as kits and articlesof manufacture comprising the pharmaceutical compositions as well as methodsof using the pharmaceutical compositions.